Page last updated: 2024-09-03

1,4,7-triazacyclononane-n,n',n''-triacetic acid and aminocaproic acid

1,4,7-triazacyclononane-n,n',n''-triacetic acid has been researched along with aminocaproic acid in 1 studies

Compound Research Comparison

Studies
(1,4,7-triazacyclononane-n,n',n''-triacetic acid)
Trials
(1,4,7-triazacyclononane-n,n',n''-triacetic acid)
Recent Studies (post-2010)
(1,4,7-triazacyclononane-n,n',n''-triacetic acid)
Studies
(aminocaproic acid)
Trials
(aminocaproic acid)
Recent Studies (post-2010) (aminocaproic acid)
19531611,793132302

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bandari, RP; Durkan, K; Hoffman, TJ; Jiang, Z; Liu, L; Miao, Y; Reynolds, TS; Rold, TL; Sieckman, GL; Smith, CJ; Szczodroski, AF1

Other Studies

1 other study(ies) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and aminocaproic acid

ArticleYear
A heterodimeric [RGD-Glu-[(64)Cu-NO2A]-6-Ahx-RM2] αvβ3/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumors.
    Nuclear medicine and biology, 2014, Volume: 41, Issue:2

    Topics: Aminocaproic Acid; Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Copper Radioisotopes; Dimerization; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Integrin alphaVbeta3; Male; Mice; Oligopeptides; Positron-Emission Tomography; Prostatic Neoplasms; Radioactive Tracers; Receptors, Bombesin

2014